Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy.
@article{Bonaldo1998CollagenVD,
title={Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy.},
author={Paolo Bonaldo and Paola Braghetta and Miriam Zanetti and Stefano Piccolo and Dino Volpin and Giorgio M. Bressan},
journal={Human molecular genetics},
year={1998},
volume={7 13},
pages={
2135-40
}
}To gain insight into the function of type VI collagen, the col6a1 gene was inactivated by targeted gene disruption in the mouse. The homozygous mutants lacked collagen VI in the tissues and showed histological features of myopathy such as fiber necrosis and phagocytosis and a pronounced variation in the fiber diameter. Muscles also showed signs of stimulated regeneration of fibers. Necrotic fibers were particularly frequent in the diaphragm at all ages examined. Similar, although milder…
270 Citations
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.
- BiologyProceedings of the National Academy of Sciences of the United States of America
- 2001
Type XV collagen appears to function as a structural component needed to stabilize skeletal muscle cells and microvessels in mice with a null mutation in the Col15a1 gene.
Cyclosporin A Promotes in vivo Myogenic Response in Collagen VI-Deficient Myopathic Mice
- BiologyFront. Aging Neurosci.
- 2014
It is shown that under appropriate administration, regimens CsA is able to stimulate myogenesis in Col6a1−/− mice by significantly increasing the number of myogenin (MyoG)-positive cells and of regenerating myofibers at the early stages of muscle regeneration.
Zebrafish models of collagen VI-related myopathies
- BiologyHuman molecular genetics
- 2010
Zebrafish models of the collagen VI myopathies are generated, successfully generating the first vertebrate model matching the clinical severity of UCMD and it is demonstrated that CsA provides phenotypic improvement, thus corroborating data from knockout mice supporting the use of mitochondrial permeability transition pore modifiers as therapeutics in patients and providing proof of principle for the utility of the zebrafish as a powerful preclinical model.
A Mouse Model for Dominant Collagen VI Disorders
- Biology, MedicineThe Journal of Biological Chemistry
- 2014
The development of a mouse model for dominant collagen VI disorders by deleting exon 16 in the Col6a3 gene, thus mimicking the most common molecular defect found in dominant Ullrich congenital muscular dystrophy patients, is reported.
Collagen type VI myopathies.
- Medicine, BiologyAdvances in experimental medicine and biology
- 2014
This review highlights the four recognized clinical phenotypes of collagen VI related - myopathies; Ullrich congenital muscular dystrophy, Bethlem myopathy, autosomal dominant limb-girdle muscular Dystrophy phenotype and autosomal recessive myosclerosis, and discusses the diagnostic criteria of these disorders.
The collagen VI-related myopathies: muscle meets its matrix
- MedicineNature Reviews Neurology
- 2011
Optimize respiratory management, including noninvasive nocturnal ventilation together with careful orthopedic management, are the current mainstays of treatment and have already led to a considerable improvement in life expectancy for children with Ullrich congenital muscular dystrophy.
Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency
- BiologyNature Genetics
- 2003
It is shown that Col6a1−/− muscles have a loss of contractile strength associated with ultrastructural alterations of sarcoplasmic reticulum and mitochondria and spontaneous apoptosis, which indicates that collagen VI myopathies have an unexpected mitochondrial pathogenesis that could be exploited for therapeutic intervention.
Muscle Weakness and Fibrosis Due to Cell Autonomous and Non-cell Autonomous Events in Collagen VI Deficient Congenital Muscular Dystrophy
- Biology, MedicineEBioMedicine
- 2017
Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond.
- BiologyMatrix biology : journal of the International Society for Matrix Biology
- 2018
Therapy of collagen VI-related myopathies (Bethlem and Ullrich)
- Medicine, BiologyNeurotherapeutics
- 2011
References
SHOWING 1-10 OF 30 REFERENCES
Reduced collagen VI causes Bethlem myopathy: a heterozygous COL6A1 nonsense mutation results in mRNA decay and functional haploinsufficiency.
- Biology, MedicineHuman molecular genetics
- 1998
This is the first example of a muscular dystrophy caused by haploinsufficiency of a structural protein or member of the dystrophin-glycoprotein complex, and identifies collagen VI as a critical contributor to cell-matrix adhesion in skeletal muscle.
Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures
- BiologyNature Genetics
- 1996
Similar to the putative perturbation of the anchoring function of the dystrophin-associated complex in congenital muscular dystrophy with mutations in the α2-subunit of laminin, the observations suggest a similar mechanism in Bethlem myopathy.
The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
- Medicine, BiologyNature
- 1991
It is proposed that dystrophin deficiency alters the threshold for work-induced injury and provides a quantitative framework for studying the pathogenesis of dystrophy and extend the application of the mdx mouse as an animal model.
Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37.
- BiologyHuman molecular genetics
- 1996
The Bethlem myopathy, a childhood onset autosomal dominant myopathy with joint contractures, has recently been localized to 21q in a series of Dutch families and the alpha 1 and alpha 2 subunits of…
Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice
- Biology, MedicineMuscle & nerve
- 1992
It is demonstrated that DIA is more affected by muscular dystrophy than hindlimb muscles, since many Duchenne patients exhibit respiratory distress, and this differential expression in diaphragm, as compared to limb muscles, may have important clinical implications.
Spatial and temporal changes of typeVI collagen expression during mouse development
- Biology
- 1996
The data show that type VI collagen is mainly produced by mesenchymal cells and suggest a role for the protein in delineating the boundary of distinct domains in connective tissue and confirm that type VII collagen is preferentially deposited in the pericellular environment.
Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees.
- MedicineBrain : a journal of neurology
- 1976
No relationship could be found between the siblings of the 3 pedigrees as far back as the beginning of the eighteenth century, and this myopathy seemed to be a new nosological entity.
Spatial and temporal changes of type VI collagen expression during mouse development.
- BiologyDevelopmental dynamics : an official publication of the American Association of Anatomists
- 1996
The data show that type VII collagen is mainly produced by mesenchymal cells and suggest a role for the protein in delineating the boundary of distinct domains in connective tissue and confirm that type VI collagen is preferentially deposited in the pericellular environment.
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.
- BiologyJournal of biochemistry
- 1995
The results indicate that degenerating muscle fibers in the mdx mouse show an increase in membrane permeability and undergo apoptosis.
Stable expression of chicken type-VI collagen α1, α2 and α3 cDNAs in murine NIH/3T3 cells
- Biology
- 1992
To investigate the behaviour of chicken type VI collagen chains in heterologous host cells as a means to understanding the pattern of assembly of this collagen, transfected murine NIH/3T3 cells with cDNAs encoding chicken α1(VI), α2( VI) and α3(VI) chains.




